Difference between revisions of "Prophylactic bilateral salpingo-oophorectomy"
Jump to navigation
Jump to search
(create) |
|||
| Line 3: | Line 3: | ||
==Grossing== | ==Grossing== | ||
*Submit ovaries and tubes in total.<ref>{{cite journal |authors=Fedda FA, Euscher ED, Ramalingam P, Malpica A |title=Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature |journal=Int J Gynecol Pathol |volume=39 |issue=4 |pages=313–320 |date=July 2020 |pmid=31851061 |doi=10.1097/PGP.0000000000000643 |url=}}</ref><ref>{{cite journal |authors=Mingels MJ, Roelofsen T, van der Laak JA, de Hullu JA, van Ham MA, Massuger LF, Bulten J, Bol M |title=Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls |journal=Gynecol Oncol |volume=127 |issue=1 |pages=88–93 |date=October 2012 |pmid=22710074 |doi=10.1016/j.ygyno.2012.06.015 |url=}}</ref> | *Submit ovaries and tubes in total.<ref>{{cite journal |authors=Fedda FA, Euscher ED, Ramalingam P, Malpica A |title=Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature |journal=Int J Gynecol Pathol |volume=39 |issue=4 |pages=313–320 |date=July 2020 |pmid=31851061 |doi=10.1097/PGP.0000000000000643 |url=}}</ref><ref>{{cite journal |authors=Mingels MJ, Roelofsen T, van der Laak JA, de Hullu JA, van Ham MA, Massuger LF, Bulten J, Bol M |title=Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls |journal=Gynecol Oncol |volume=127 |issue=1 |pages=88–93 |date=October 2012 |pmid=22710074 |doi=10.1016/j.ygyno.2012.06.015 |url=}}</ref> | ||
==Sign out== | |||
<pre> | |||
Fallopian Tubes and Ovaries, Bilateral Salpingo-Oophorectomy: | |||
- Benign ovaries and Fallopian tubes. | |||
- NEGATIVE for malignancy. | |||
</pre> | |||
==See also== | ==See also== | ||
Latest revision as of 16:09, 21 May 2024
Prophylactic bilateral salpingo-oophorectomy are done to prevent the development of cancer - when there is a genetic predisposition.
Grossing
Sign out
Fallopian Tubes and Ovaries, Bilateral Salpingo-Oophorectomy: - Benign ovaries and Fallopian tubes. - NEGATIVE for malignancy.
See also
References
- ↑ Fedda FA, Euscher ED, Ramalingam P, Malpica A (July 2020). "Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature". Int J Gynecol Pathol 39 (4): 313–320. doi:10.1097/PGP.0000000000000643. PMID 31851061.
- ↑ Mingels MJ, Roelofsen T, van der Laak JA, de Hullu JA, van Ham MA, Massuger LF, Bulten J, Bol M (October 2012). "Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls". Gynecol Oncol 127 (1): 88–93. doi:10.1016/j.ygyno.2012.06.015. PMID 22710074.